Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

Human medicines European Public Assessment Report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Revision: 10, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Revision: 11, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Revision: 12, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), irbesartan / hydrochlorothiazide, Revision: 15, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan Teva, irbesartan, Revision: 3, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan Teva, irbesartan, Revision: 4, Authorised

Human medicines European Public Assessment Report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Revision: 3, Authorised

Aimix amlodipine besilate/irbesartan regulatory update

FDA approves Mylan Irbesartan ANDA

Mylan Pharmaceuticals has won FDA approval for its abbreviated new drug application (ANDA) for Irbesartan Tablets USP, 75mg, 150mg and 300mg, the generic version of Sanofi's Avapro.

Human medicines European Public Assessment Report (EPAR): Irbesartan / Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Revision: 4, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan/Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Revision: 4, Authorised

Teva UK introduces generic Irbesartan tablets

Teva UK, a part of Teva Pharmaceutical Industries, has announced the launch of generic Irbesartan tablets.

[Clinical Picture] Phantom tumour of the lung

A 79-year-old man presented with an 8 h history of shortness of breath and oedematous legs. He had a history of hypertension, atrial fibrillation, and chronic obstructive pulmonary lung disease. He was on long term ipratropium bromide, irbesartan, am...

Dainippon Sumitomo Pharma and Shionogi to co-market antihypertensive DSP-8153

Dainippon Sumitomo Pharma (DSP; TYO: 4506) has entered into a license accord with fellow Japanese drugmaker Shionogi (TYO: 4507) for the co-marketing in Japan of DSP-8153, a combination product of the anti-hypertension drugs irbesartan and amlodipine...

Teva launches generic Aprovel in UK

The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugmaker, yesterday announced the launch of generic Irbesartan tablets in the UK. Irbesartan is a generic version of Aprovel from France's Sanofi...

Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension

Mylan Launches Generic Avapro® Tablets and Generic Avalide® Tablets

PITTSBURGH, Sept. 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Irbesartan Tablets USP, 75 mg, 150 mg and 300 mg, the generic version of Sanofi's Avapro®. The company also received final approva...

Irbesartan/trichloromethiazide regulatory update

Human medicines European Public Assessment Report (EPAR): Karvea, irbesartan, Revision: 28, Authorised

Human medicines European Public Assessment Report (EPAR): Aprovel, irbesartan, Revision: 28, Authorised

Human medicines European Public Assessment Report (EPAR): Aprovel, irbesartan, Revision: 26, Authorised

Human medicines European Public Assessment Report (EPAR): Karvea, irbesartan, Revision: 27, Authorised

Human medicines European Public Assessment Report (EPAR): Aprovel, irbesartan, Revision: 27, Authorised

Human medicines European Public Assessment Report (EPAR): Karvezide, irbesartan / hydrochlorothiazide, Revision: 27, Authorised

Human medicines European Public Assessment Report (EPAR): CoAprovel, irbesartan / hydrochlorothiazide, Revision: 26, Authorised